Bedinvetmab
Bedinvetmab
Bedinvetmab is a monoclonal antibody used in veterinary medicine, specifically for the treatment of osteoarthritis in dogs. It is part of a class of drugs known as anti-NGF (nerve growth factor) antibodies, which are designed to alleviate pain associated with osteoarthritis by inhibiting the action of NGF, a protein involved in pain signaling.
Mechanism of Action[edit | edit source]
Bedinvetmab works by targeting and binding to nerve growth factor (NGF), a key mediator in the pain pathway. By inhibiting NGF, bedinvetmab reduces pain and inflammation associated with osteoarthritis in dogs. This mechanism is similar to that of other anti-NGF therapies, which are being explored for use in both human and veterinary medicine.
Uses[edit | edit source]
Bedinvetmab is primarily used for the management of pain associated with osteoarthritis in dogs. Osteoarthritis is a common condition in aging dogs, characterized by the degeneration of joint cartilage and the underlying bone, leading to pain and stiffness. Bedinvetmab provides an alternative to traditional pain management strategies, such as non-steroidal anti-inflammatory drugs (NSAIDs).
Administration[edit | edit source]
Bedinvetmab is administered via subcutaneous injection. The dosage and frequency of administration depend on the specific product formulation and the veterinarian's assessment of the dog's condition. It is important for the administration to be carried out by a qualified veterinary professional.
Side Effects[edit | edit source]
As with any medication, bedinvetmab may cause side effects. Common side effects include mild injection site reactions, such as swelling or redness. More serious side effects are rare but can occur. It is important for pet owners to monitor their dogs for any adverse reactions and consult their veterinarian if they have concerns.
Regulatory Status[edit | edit source]
Bedinvetmab has been approved for use in several countries for the treatment of osteoarthritis in dogs. The approval process involves rigorous testing to ensure the safety and efficacy of the drug for its intended use.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
